erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys
RNA binding protein ILF3 increases CEP55 mRNA stability to enhance malignant potential of breast cancer cells and suppress ferroptosis. (PubMed, Hereditas) - Jan 28, 2025 - "Our observations indicate that the depletion of ILF3 impairs the malignant potential of BC cells and promotes their ferroptosis by downregulating CEP55 expression. Silencing ILF3 or CEP55 could represent a potential therapeutic strategy for BC treatment." 
Journal • Breast Cancer • Oncology • Solid Tumor • CEP55
http://www.ncbi.nlm.nih.gov/pubmed/39871389
 
Guosen Su; Guoxing Huang; Sheng Chen; Simin Ruan; Yangyong Luo
 
Jan 28, 2025
 
Prev Next